Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings.

Autor: Shaw JLV; Division of Biochemistry, Eastern Ontario Regional Laboratory Association and The Ottawa Hospital, and Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada., Bannuru RR; American Diabetes Association, Arlington, VA., Beach L; Division of Biochemistry, IWK Health, Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Nova Scotia, Canada., ElSayed NA; American Diabetes Association, Arlington, VA.; Harvard Medical School, Cambridge, MA., Freckmann G; Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany., Füzéry AK; Alberta Precision Laboratories, Edmonton, Alberta, Canada.; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada., Fung AWS; Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Providence Health Care and University of British Columbia, Vancouver, British Columbia, Canada., Gilbert J; Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Huang Y; Division of Biochemistry, Kingston Health Sciences Centre, and Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada., Korpi-Steiner N; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Logan S; Alberta Precision Laboratories, Edmonton, Alberta, Canada.; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Longo R; Lahey Hospital & Medical Center, Burlington, MA., MacKay D; Departments of Food and Human Nutritional Sciences and Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Maks L; Providence Health Care, Vancouver, British Columbia, Canada., Pleus S; Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany., Rogers K; Division of Hospital Medicine, Department of Internal Medicine, The University of New Mexico School of Medicine, Albuquerque, NM., Seley JJ; Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York, NY., Taxin Z; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Thompson-Hutchison F; Integrated Community Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Tolan NV; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Tran NK; Department of Pathology and Laboratory Medicine, UC Davis Health, University of California, Davis, Sacramento, CA., Umpierrez GE; Division of Endocrinology and Metabolism, Department of Medicine, Emory School of Medicine, Emory University, Atlanta, GA., Venner AA; Alberta Precision Laboratories, Edmonton, Alberta, Canada.; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Publikováno v: Diabetes care [Diabetes Care] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.

Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl.

Autor: Uljon S; Department of Pathology, Massachusetts General Hospital, Boston, MA, United States.; Department of Pathology, Harvard Medical School, Boston, MA, United States., Tolan NV; Department of Pathology, Harvard Medical School, Boston, MA, United States.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Mahowald GK; Department of Pathology, Massachusetts General Hospital, Boston, MA, United States.; Department of Pathology, Harvard Medical School, Boston, MA, United States., Khaliq T; Department of Pathology, Massachusetts General Hospital, Boston, MA, United States., Urwiller ED; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Fernandes MD; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Basu SS; Department of Pathology, Harvard Medical School, Boston, MA, United States.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Kang P; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Erickson TB; Department of Pathology, Harvard Medical School, Boston, MA, United States.; Department of Emergency Medicine, Division of Medical Toxicology, Brigham and Women's Hospital, Boston, MA, United States., Hayes BD; Department of Pathology, Harvard Medical School, Boston, MA, United States.; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, United States., Chai PR; Department of Pathology, Harvard Medical School, Boston, MA, United States.; Department of Emergency Medicine, Division of Medical Toxicology, Brigham and Women's Hospital, Boston, MA, United States., Melanson SEF; Department of Pathology, Harvard Medical School, Boston, MA, United States.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.

Publikováno v: The journal of applied laboratory medicine [J Appl Lab Med] 2024 Sep 03; Vol. 9 (5), pp. 895-904.

Despite the improved clinical sensitivity of the Roche benzodiazepines II assay it cannot replace mass spectrometry in all patient populations.

Autor: Tolan NV; Department of Pathology, Mass General Brigham, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Uljon S; Department of Pathology, Mass General Brigham, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Lauren Donnelly-Morell M; Department of Pathology, Mass General Brigham, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Zhao M; Department of Pathology, Mass General Brigham, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Mahowald GK; Department of Pathology, Mass General Brigham, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Snyder ML; Luxor Scientific, Greenville, SC, United States., Contella L; Luxor Scientific, Greenville, SC, United States., Urwiller ED; Department of Pathology, Mass General Brigham, Boston, MA, United States., Daluz Fernandes M; Department of Pathology, Mass General Brigham, Boston, MA, United States., Kang P; Department of Pathology, Mass General Brigham, Boston, MA, United States., Melanson SEF; Department of Pathology, Mass General Brigham, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.

Publikováno v: Journal of mass spectrometry and advances in the clinical lab [J Mass Spectrom Adv Clin Lab] 2024 Jun 25; Vol. 33, pp. 14-20. Date of Electronic Publication: 2024 Jun 25 (Print Publication: 2024).

Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utility.

Autor: Tolan NV; Brigham and Women's Hospital, Department of Pathology, Boston, MA, United States; Harvard Medical School, Boston, MA, United States. Electronic address: ntolan@bwh.harvard.edu., DeSimone MS; Brigham and Women's Hospital, Department of Pathology, Boston, MA, United States; Harvard Medical School, Boston, MA, United States., Fernandes MD; Brigham and Women's Hospital, Department of Pathology, Boston, MA, United States., Lewis JE; Brigham and Women's Hospital, Department of Pathology, Boston, MA, United States; Harvard Medical School, Boston, MA, United States., Simmons DP; Brigham and Women's Hospital, Department of Pathology, Boston, MA, United States; Harvard Medical School, Boston, MA, United States., Schur PH; Brigham and Women's Hospital, Department of Pathology, Boston, MA, United States; Harvard Medical School, Boston, MA, United States., Brigl M; Brigham and Women's Hospital, Department of Pathology, Boston, MA, United States; Harvard Medical School, Boston, MA, United States., Tanasijevic MJ; Brigham and Women's Hospital, Department of Pathology, Boston, MA, United States; Harvard Medical School, Boston, MA, United States., Desjardins M; Harvard Medical School, Boston, MA, United States; Brigham and Women's Hospital, Department of Medicine, Division of Infectious Diseases, Boston, MA, United States., Sherman AC; Harvard Medical School, Boston, MA, United States; Brigham and Women's Hospital, Department of Medicine, Division of Infectious Diseases, Boston, MA, United States., Baden LR; Harvard Medical School, Boston, MA, United States; Brigham and Women's Hospital, Department of Medicine, Division of Infectious Diseases, Boston, MA, United States., Snyder M; Luxor Scientific, Greenville, SC, United States., Melanson SE; Brigham and Women's Hospital, Department of Pathology, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.

Publikováno v: Clinical biochemistry [Clin Biochem] 2023 Jul; Vol. 117, pp. 60-68. Date of Electronic Publication: 2023 Mar 05.

Cannabis positivity rates in 17 emergency departments across the United States with varying degrees of marijuana legalization.

Autor: Tolan NV; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Krasowski MD; Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA., Mathias PC; Department of Laboratory Medicine and Pathology, Department of Biomedical Informatics and Medical Education, University of Washington School of Medicine, Seattle, WA, USA., Wiencek JR; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA., Babic N; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA., Chai PR; Harvard Medical School, Boston, MA, USA.; Department of Emergency Medicine, Division of Medical Toxicology, Brigham and Women's Hospital, Boston, MA, USA.; The Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; The Fenway Institute, Boston, MA, USA., Chambliss AB; Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA., Choucair I; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA., Demetriou CA; Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus, USA., Erickson TB; Harvard Medical School, Boston, MA, USA.; Department of Emergency Medicine, Division of Medical Toxicology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Humanitarian Initiative, Cambridge, MA, USA., Feldhammer M; Department of Pathology and Laboratory Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, FL, USA., French D; Department of Laboratory Medicine, University of San Francisco, San Francisco, CA, USA., Hayes BD; Harvard Medical School, Boston, MA, USA.; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA., Kang P; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., El-Khoury JM; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA., Knezevic CE; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Monte A; University of Colorado Anschutz, Aurora, CO, USA., Nerenz RD; Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.; Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Okorodudu AO; University of Texas Medical Branch, Galveston, TX, USA., Roper SM; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA., Saitman A; Providence Regional Laboratories, Portland, OR, USA., Thiriveedhi V; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Uljon SN; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Vest A; University of Colorado Anschutz, Aurora, CO, USA., Woodworth A; Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, USA., Yu M; Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, USA., Melanson SEF; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.

Publikováno v: Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2023 Apr; Vol. 61 (4), pp. 248-259.